Heike Voigt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Heike Voigt

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

European Journal of Immunology|September 24, 2004

Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopesAndreas O Eggert, Mads H Andersen, Heike Voigt, et al.

Cancer Immunology, Immunotherapy : CII|December 30, 2006

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expressionMarion Wobser, Heike Voigt, Roland Houben, et al.

Cancer Immunology, Immunotherapy : CII|October 2, 2008

The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell linesRikke Baek Sørensen, Niels Junker, Alexei Kirkin, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008

Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB/c miceCatherine Ronet, Heike Voigt, Hayo Himmelrich, et al.

Cancer Immunology, Immunotherapy : CII|July 3, 2007

Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissueDavid Schrama, Heike Voigt, Andreas O Eggert, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008

Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2DMathias Krockenberger, Yvonne Dombrowski, Claudia Weidler, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

European Journal of Immunology|September 24, 2004

Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopesAndreas O Eggert, Mads H Andersen, Heike Voigt, et al.

Cancer Immunology, Immunotherapy : CII|December 30, 2006

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expressionMarion Wobser, Heike Voigt, Roland Houben, et al.

Cancer Immunology, Immunotherapy : CII|October 2, 2008

The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell linesRikke Baek Sørensen, Niels Junker, Alexei Kirkin, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008

Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB/c miceCatherine Ronet, Heike Voigt, Hayo Himmelrich, et al.

Cancer Immunology, Immunotherapy : CII|July 3, 2007

Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissueDavid Schrama, Heike Voigt, Andreas O Eggert, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008

Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2DMathias Krockenberger, Yvonne Dombrowski, Claudia Weidler, et al.

Pageof 2